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Metastatic	  Breast	  Cancer	  Presenting	  as	  Painless	  Jaundice
Daniel S. Wilen, D.O.1, Donald J. McMahon, D.O.2, Brian J. Blair, D.O.2, Joanne Kaiser-Smith, D.O.1, Darshan B. Roy, M.D.3
Breast	  cancer	  is	  the	  most	  commonly	  diagnosed	  cancer	  in	  
women	  in	  the	  United	  States.	  Treatment	  options	  are	  wide-­‐
ranging	  based	  on	  a	  multitude	  of	  factors,	  including	  extent	  of	  
disease	  and	  receptor	  positivity.	  	  Following	  treatment,	  a	  
relapse-­‐free	  interval	  ≥	  2	  years	  carries	  a	  more	  favorable	  
prognosis.
We	  present	  a	  case	  involving	  a	  female	  with	  history	  of	  breast	  
cancer	  and	  relapse-­‐free	  interval	  of	  15	  years	  who	  unfortunately	  
presented	  with	  metastatic	  disease	  involving	  the	  liver,	  bone,	  
and	  lymph	  nodes	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Papanicolaou	  stain,	  (A,	  40x)	  showing	  numerous	  large	  atypical	  
cells	  with	  high	  nuclear	  to	  cytoplasmic	  ratios.	  H&E	  stain	  (B,	  
10x)	  of	  the	  core	  biopsy	  showing	  this	  infiltrate	  within	  the	  liver	  
parenchyma.	  	  Additional	  immunohistochemical	  stains	  show	  
these	  cells	  are	  positive	  for	  GATA3	  (C,	  10x)	  ,	  GDCDFP-­‐15	  (D,	  
10x),	  mammaglobin	  (E,	  10x),	  and	  ER	  (F,	  10x).
• 56	  year	  old	  female	  presented	  for	  evaluation	  of	  painless	  
jaundice,	  first	  noticed	  by	  family	  members	  within	  one	  week	  
prior	  to	  arrival
• PMH	  significant	  for	  breast	  cancer	  20	  years	  ago	  treated	  with	  
right	  mastectomy	  with	  adjuvant	  chemotherapy	  and	  radiation.	  
Cleared	  by	  Oncology	  5	  years	  post-­‐treatment
• Right	  upper	  quadrant	  ultrasound	  revealed	  poorly	  defined	  
mass	  in	  right	  lobe	  of	  liver,	  sludge	  within	  gallbladder,	  and	  
intrahepatic	  ductal	  dilatation	  suggesting	  distal	  common	  bile	  
duct	  obstruction
• Follow	  up	  MRCP	  showed	  extensive	  hepatic	  metastases	  with	  
innumerable	  liver	  lesions
• Patient	  underwent	  ERCP,	  where	  a	  pancreatic	  duct	  stent	  was	  
deployed	  but	  common	  bile	  duct	  could	  not	  be	  cannulated
• Internal/external	  biliary	  drainage	  catheter	  was	  placed	  by	  
Interventional	  Radiology	  secondary	  to	  complete,	  abrupt	  
obstruction	  of	  distal	  common	  bile	  duct
• Hepatic	  lesion	  biopsy	  was	  positive	  for	  primary	  mammary	  
malignancy	  
• A	  review	  of	  the	  literature	  revealed	  only	  a	  select	  number	  of	  
cases	  where	  patients	  presented	  with	  painless	  jaundice	  
deemed	  secondary	  to	  metastatic	  breast	  cancer.	  	  This	  is	  the	  
first	  such	  case	  in	  which	  the	  patient	  already	  had	  a	  previous	  
diagnosis	  of	  breast	  cancer,	  irrespective	  of	  prior	  treatment.
• In	  patients	  with	  malignant	  obstruction,	  biliary	  stenting	  has	  
been	  shown	  to	  improve	  jaundice	  and	  deliver	  improved	  quality	  
of	  life.
• For	  unresectable malignant	  biliary	  obstruction,	  palliative	  
treatment	  options	  include	  surgical	  bypass,	  percutaneous	  
drainage,	  and	  endoscopic	  drainage	  with	  plastic	  or	  metal	  
biliary	  stents.	  Studies	  comparing	  these	  treatment	  options	  in	  
this	  patient	  population	  concluded	  that	  endoscopic	  metal	  
stents	  are	  the	  treatment	  of	  choice	  
• In	  patients	  with	  known	  malignancy,	  the	  development	  of	  
jaundice	  may	  indicate	  hepatic	  or	  biliary	  metastasis	  with	  bile	  
duct	  obstruction.
• While	  a	  multidisciplinary	  approach	  to	  treatment	  is	  necessary,	  
biliary	  stenting	  to	  relieve	  obstruction	  is	  a	  viable	  option	  for	  
palliation.
MRI	  of	  abdomen:	  axial	  image	  showing	  extensive	  hepatic	  
metastases	  with	  innumerable	  liver	  lesions	  of	  varying	  shape	  
and	  size.	  
